A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation

Haya Al-Fozan, Maha Al-Khadouri, Seang Lin Tan, Togas Tulandi

Research output: Contribution to journalArticle

131 Citations (Scopus)

Abstract

To compare the effects of the aromatase inhibitor letrozole (7.5 mg) and clomiphene citrate (CC; 100 mg) in women undergoing superovulation and IUI. Prospective randomized trial. University teaching hospital. We studied a total of 238 cycles of superovulation and IUI in women with idiopathic infertility. Patients were randomized into treatment with 7.5 mg of letrozole daily (74 patients, 115 cycles) or 100 mg of CC daily (80 patients, 123 cycles). Number of follicles, endometrial thickness, pregnancy rate, and miscarriage rate. The mean age, parity, and duration of infertility in both groups of patients were similar. There was no significant difference between the total number of developing follicles in the letrozole (5.7 ± 3.7) and in the CC groups (4.8 ± 2.5). The number of follicles of <14 mm and of >18 mm were 2.1 ± 1.2 and 1.4 ± 0.7 in the letrozole group, and 1.7 ± 0.9 and 1.1 ± 0.5 in the CC group, respectively. No difference was found in the endometrial thickness between the two groups (7.1 ± 0.2 mm in the letrozole group, 8.2 ± 5.9 mm in the CC group). The pregnancy rate per cycle was 11.5% in the letrozole group and 8.9% in the CC group. Four of the 11 pregnancies in the CC group resulted in a miscarriage (36.6%). Superovulation and IUI with letrozole and CC are associated with similar pregnancy rates, but the miscarriage rate is higher with CC. The ideal dose of letrozole remains unknown and further study is needed.

Original languageEnglish
Pages (from-to)1561-1563
Number of pages3
JournalFertility and Sterility
Volume82
Issue number6
DOIs
Publication statusPublished - Dec 2004

Fingerprint

letrozole
Superovulation
Clomiphene
Spontaneous Abortion
Pregnancy Rate
Infertility
Aromatase Inhibitors
Parity
Teaching Hospitals

Keywords

  • clomiphene
  • letrozole
  • ovulation
  • Randomized trial
  • superovulation

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynaecology

Cite this

A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. / Al-Fozan, Haya; Al-Khadouri, Maha; Tan, Seang Lin; Tulandi, Togas.

In: Fertility and Sterility, Vol. 82, No. 6, 12.2004, p. 1561-1563.

Research output: Contribution to journalArticle

Al-Fozan, Haya ; Al-Khadouri, Maha ; Tan, Seang Lin ; Tulandi, Togas. / A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. In: Fertility and Sterility. 2004 ; Vol. 82, No. 6. pp. 1561-1563.
@article{4c850925472e44dca3cad0873a7af6f6,
title = "A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation",
abstract = "To compare the effects of the aromatase inhibitor letrozole (7.5 mg) and clomiphene citrate (CC; 100 mg) in women undergoing superovulation and IUI. Prospective randomized trial. University teaching hospital. We studied a total of 238 cycles of superovulation and IUI in women with idiopathic infertility. Patients were randomized into treatment with 7.5 mg of letrozole daily (74 patients, 115 cycles) or 100 mg of CC daily (80 patients, 123 cycles). Number of follicles, endometrial thickness, pregnancy rate, and miscarriage rate. The mean age, parity, and duration of infertility in both groups of patients were similar. There was no significant difference between the total number of developing follicles in the letrozole (5.7 ± 3.7) and in the CC groups (4.8 ± 2.5). The number of follicles of <14 mm and of >18 mm were 2.1 ± 1.2 and 1.4 ± 0.7 in the letrozole group, and 1.7 ± 0.9 and 1.1 ± 0.5 in the CC group, respectively. No difference was found in the endometrial thickness between the two groups (7.1 ± 0.2 mm in the letrozole group, 8.2 ± 5.9 mm in the CC group). The pregnancy rate per cycle was 11.5{\%} in the letrozole group and 8.9{\%} in the CC group. Four of the 11 pregnancies in the CC group resulted in a miscarriage (36.6{\%}). Superovulation and IUI with letrozole and CC are associated with similar pregnancy rates, but the miscarriage rate is higher with CC. The ideal dose of letrozole remains unknown and further study is needed.",
keywords = "clomiphene, letrozole, ovulation, Randomized trial, superovulation",
author = "Haya Al-Fozan and Maha Al-Khadouri and Tan, {Seang Lin} and Togas Tulandi",
year = "2004",
month = "12",
doi = "10.1016/j.fertnstert.2004.04.070",
language = "English",
volume = "82",
pages = "1561--1563",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation

AU - Al-Fozan, Haya

AU - Al-Khadouri, Maha

AU - Tan, Seang Lin

AU - Tulandi, Togas

PY - 2004/12

Y1 - 2004/12

N2 - To compare the effects of the aromatase inhibitor letrozole (7.5 mg) and clomiphene citrate (CC; 100 mg) in women undergoing superovulation and IUI. Prospective randomized trial. University teaching hospital. We studied a total of 238 cycles of superovulation and IUI in women with idiopathic infertility. Patients were randomized into treatment with 7.5 mg of letrozole daily (74 patients, 115 cycles) or 100 mg of CC daily (80 patients, 123 cycles). Number of follicles, endometrial thickness, pregnancy rate, and miscarriage rate. The mean age, parity, and duration of infertility in both groups of patients were similar. There was no significant difference between the total number of developing follicles in the letrozole (5.7 ± 3.7) and in the CC groups (4.8 ± 2.5). The number of follicles of <14 mm and of >18 mm were 2.1 ± 1.2 and 1.4 ± 0.7 in the letrozole group, and 1.7 ± 0.9 and 1.1 ± 0.5 in the CC group, respectively. No difference was found in the endometrial thickness between the two groups (7.1 ± 0.2 mm in the letrozole group, 8.2 ± 5.9 mm in the CC group). The pregnancy rate per cycle was 11.5% in the letrozole group and 8.9% in the CC group. Four of the 11 pregnancies in the CC group resulted in a miscarriage (36.6%). Superovulation and IUI with letrozole and CC are associated with similar pregnancy rates, but the miscarriage rate is higher with CC. The ideal dose of letrozole remains unknown and further study is needed.

AB - To compare the effects of the aromatase inhibitor letrozole (7.5 mg) and clomiphene citrate (CC; 100 mg) in women undergoing superovulation and IUI. Prospective randomized trial. University teaching hospital. We studied a total of 238 cycles of superovulation and IUI in women with idiopathic infertility. Patients were randomized into treatment with 7.5 mg of letrozole daily (74 patients, 115 cycles) or 100 mg of CC daily (80 patients, 123 cycles). Number of follicles, endometrial thickness, pregnancy rate, and miscarriage rate. The mean age, parity, and duration of infertility in both groups of patients were similar. There was no significant difference between the total number of developing follicles in the letrozole (5.7 ± 3.7) and in the CC groups (4.8 ± 2.5). The number of follicles of <14 mm and of >18 mm were 2.1 ± 1.2 and 1.4 ± 0.7 in the letrozole group, and 1.7 ± 0.9 and 1.1 ± 0.5 in the CC group, respectively. No difference was found in the endometrial thickness between the two groups (7.1 ± 0.2 mm in the letrozole group, 8.2 ± 5.9 mm in the CC group). The pregnancy rate per cycle was 11.5% in the letrozole group and 8.9% in the CC group. Four of the 11 pregnancies in the CC group resulted in a miscarriage (36.6%). Superovulation and IUI with letrozole and CC are associated with similar pregnancy rates, but the miscarriage rate is higher with CC. The ideal dose of letrozole remains unknown and further study is needed.

KW - clomiphene

KW - letrozole

KW - ovulation

KW - Randomized trial

KW - superovulation

UR - http://www.scopus.com/inward/record.url?scp=10044249053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10044249053&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2004.04.070

DO - 10.1016/j.fertnstert.2004.04.070

M3 - Article

VL - 82

SP - 1561

EP - 1563

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 6

ER -